Skip to content

Anne Weisman

5 papers in the library · 2 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

The Efficacy of Hypnotherapy in Reducing Burnout and Related Psychopathologies: Protocol for a Systematic Review and Meta-Analysis.

JMIR Research Protocols July 17, 2026 Santosha Veeramachaneni, Elizabeth Park, Jeffrey Martin et al.

Hypnosis is a focused state of consciousness that enhances concentration, attention, and responsiveness to suggestion. It has shown efficacy in treating psychiatric disorders such as depression, anxiety, and posttraumatic stress disorder (PTSD). However, its potential for addressing burnout and related symptoms remains underexplored. This systematic review and meta-analysis aims to assess the...

Examining the influence of team-based learning on medical students’ comprehension and attitudes regarding psychedelic therapies

Dialogues in Clinical Neuroscience September 2, 2024 Shiven Chaudhry, Anne Weisman, Molly M. Hagen et al.

INTRODUCTION: This study evaluates the impact of a two-hour team-based learning (TBL) curriculum on medical students' knowledge, comprehension, ethical understanding, and attitudes towards psychedelic therapies. METHODS: Sixty-three pre-surveys and fifty post-surveys assessed students' perceived knowledge and attitudes using Likert scales. Forty-eight matched pre/post-knowledge tests with...

Unraveling the Mysteries of Mental Illness With Psilocybin

Cureus May 27, 2022 Robert Sotille, Herpreet Singh, Anne Weisman et al. 2 citations

Current medications have not been effective in reducing the prevalence of mental illness worldwide. The prevalence of illnesses such as treatment-resistant depression has increased despite the widespread use of a broad set of psychopharmaceuticals. Transcranial magnetic stimulation and ketamine therapy are making great strides in improving treatment-resistant depression outcomes but they have...

Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT)

Burton J. Tabaac, Kenneth Shinozuka, Anne Weisman et al. preprint

Background: 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), also officially known as Mebufotenin, is a naturally occurring serotonergic psychedelic alkaloid found in the venom of the Sonoran Desert toad (Incilius alvarius) and various plant species. Areas of Uncertainty: Trace levels of 5-MeO-DMT may be produced endogenously in humans, but its physiological role remains unclear. Safety profiles...